BioCorRx Inc. (BICX) — Annual Report

Key Insights

• The company entered into multiple amendments to a promissory note, extending the maturity date and issuing additional restricted stock to the debt holder. This suggests the company may be facing liquidity or financing challenges.
• The company has a history of raising capital through the issuance of common stock, preferred stock, and convertible securities. This ongoing need for financing could indicate difficulties in generating sufficient revenue and cash flow.
• The company's financial statements show accumulated losses and a reliance on external funding, which raises concerns about its long-term viability and ability to become profitable.